Search results (3228)
« Back to PublicationsDNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanoma.
Journal article
Garralda E. et al, (2026), Clinical cancer research : an official journal of the American Association for Cancer Research
Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF.
Journal article
Ma B. et al, (2026), Science immunology, 11
Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I
Preprint
Murali TM. et al, (2026)
Intratumoral heterogeneity and immunotherapy resistance: clinical implications.
Journal article
Keenan BP. et al, (2026), Annals of oncology : official journal of the European Society for Medical Oncology, 37, 314 - 328
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.
Journal article
Sanmamed MF. et al, (2026), Clinical cancer research : an official journal of the American Association for Cancer Research, 32, 1036 - 1045
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis.
Journal article
Beernaert B. et al, (2026), Science advances, 12
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B.
Journal article
Kalafateli M. et al, (2026), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 24, 701 - 712.e8
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.
Journal article
Conti AG. et al, (2026), Nature immunology, 27, 436 - 451